Vikner, Tomas
Johnson, Kevin M.
Cadman, Robert V.
Betthauser, Tobey J.
Wilson, Rachael E.
Chin, Nathaniel
Eisenmenger, Laura B.
Johnson, Sterling C.
Rivera-Rivera, Leonardo A.
Funding for this research was provided by:
Hjärnfonden (PS2023-0047)
National Institutes of Health, United States (R01AG075788, KL2TR002374, R01AG027161, R21AG077337)
Alzheimer’s Association (AARFD-20-678095)
Article History
Received: 9 May 2024
Accepted: 19 August 2024
First Online: 30 August 2024
Declarations
:
: The University of Wisconsin Institutional Review Board approved all study procedures and protocols following the policies and guidance established by the campus Human Research Protection Program (HRPP). Each participant signed a written informed consent before participation.
: Not applicable.
: Sterling C. Johnson served on an advisory board for Roche Diagnostics in 2018 for which he received an honorarium and is principal investigator of an equipment grant from Roche. He conducts tau imaging in NIH funded studies as well as a study funded by Cerveau Technologies using radioligand precursor material supplied by Cerveau Technologies.